Antibe Closes Previously Announced Strategic Sale of Citagenix Subsidiary 2022-11-02 Antibe Therapeutics is pleased to announce the closing of the sale of its Citagenix Inc. subsidiary to HANSAmed Limited (“HANSAmed”), a leading Canadian distributor of